Dr. Agarwals Health Care Ltd (AGARWALEYE) Q4FY26 Management Mirror - Mar-2026 Qtr
Financial & Margin Outlook
Management provided fresh guidance for FY27 in the Mar'26 quarter, expecting top-line growth to sustain at a similar pace to the prior year, driven by deeper micro-market penetration and advanced surgical adoptions. EBITDA margins are projected to remain stable in FY27 despite aggressive new facility investments, continuing the trend of margin stability emphasized in the Sep'25 quarter for FY26. Additionally, the Dec'25 quarter noted an anticipated recovery in refractive surgery volumes for FY27 following industry-wide sluggishness. [Status: Initiated]
3 more themes on the ELITE plan.